Inflarx Nv

Penny Stocks Biotech Stocks Healthcare Stocks

$2.47

+0.09 (+3.78%)

As of May 16, 2:18 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 79%

Hold 3 21%

Sell 0 0%

Price Target

Analyst Price Target +142.9% upside

Low Target $4.29

Average Target $6.00

High Target $7.91

Current Price $2.47

Current
$2.47

Target
$6.00

$4.29 $6.00 avg $7.91

Scenario Analysis

Bear Case

$4.29

73.7%

Low target

Base Case

$6.00

+142.9%

Avg target

Bull Case

$7.91

+220.2%

High target

Risk/Reward

3.0x

Favorable

Price in Context

52-Week High

$2.95

-16.2% from high

52-Week Low

$0.71

+247.3% from low

Target vs 52W High

$6.00

+103.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%